Join the club for FREE to access the whole archive and other member benefits.

Crowd funding success for OncoSENS Control ALT Delete Cancer

18-Sep-2016

Key points from article :

$72,000 raised for high-throughput screening of a library of diverse drugs to find treatments for ‘ALT’ cancers.

ALT cancers rely on Alternative Lengthening of Telomeres.

Telomere shortening acts as a biological mechanism for limiting cellular life span.

Most cancer cells bypass this failsafe by synthesizing new telomeres using the enzyme telomerase.

There are currently no ALT-targeted anti-cancer therapeutics.

The study was published in the PubMed Central.

Mentioned in this article:

Tap on icon for description, click on resource name for more details.

Journal

PubMed Central is a full text repository, which contains the full text of publications in the database